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The health benefits and medicinal properties of herbal food products are known since antiquity. Fenugreek, Trigonella foenum-graecum Linn (T. 
foenum-graecum, Fabaceae), a seed spice used to enhance flavor, color and texture of food is employed for medicinal purposes in many 
traditional systems.  Ethno botanical survey of T. foenum-graecum revealed the seeds of the plant to be useful in anemia. The objective of this 
study was to study the ant-anemic effect of hydroalcoholic extract of seeds of T. foenum-graecum against phenylhydrazine induced anemic rat 
model. The hydroalcoholic extracts of seeds were prepared by soxhlation. Phytochemical analysis of the extracts was performed using standard 
testing procedures. Hemolytic anemia was induced in male Wistar rats by intraperitoneal administration of phenylhydrazine HCl (PHZ) at 
doses of 40 mg/kg of body weight during two successive days then one day after the animals were treated orally by the hydroalcoholic extracts 
with the amounts of 200 mg/kg and 400 mg/kg of body weight and Dexorange (reference drug) up to 13 days. The rats were analyz ed for 
hematological parameters such as hemoglobin (Hb), red blood cell count (RBC) and white blood cell count (WBC) on day 2 and 13. 
Phytochemical screening of the extracts indicated the presence of carbohydrates, saponins, sterols, polyphenols, tannins and flavonoids. 
Anemia was induced successfully in Groups II, III, IV and V which was indicated by a mean reduction of 51.6% in RBC count; 52.85% in Hb 
content and 54.9% in WBC. Analysis of hematological parameters on day 13 showed that extract significantly (p<0.05) improved Hb, RBC and 
WBC count at a dose of 400 mg/kg body weight. This study, not only substantiates the folklore use of the seed of T. foenum-graecum, but also 
suggests its inclusion in the treatment of anemia as it exhibited significant anti-anemic activity 
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Certain diseases such as malaria, malnutrition, protozoa 
infections and pregnancy are among various conditions that 
may lead to anemia in both adults and children. Anemia is a 
condition, wherein the quantity of circulating hemoglobin 
(Hb) in the blood is <13 g/dl for male and <12 g/dl for 
female adult1. There are several types of anemia and all are 
characterized by a reduction in a number of circulating red 
blood cells (RBC) and Hb2. The consequences of anemia 
included general body weakness, frequent tiredness and 
lowered resistance to disease. Anemic condition if not 
treated, may lead to serious problems in pregnant women 
such as premature delivery and low birth weight. It is of 
concern in children in whom anemia is associated with 
impaired mental and physical development. Anemia is a 
condition commonly seen in developing countries because of 
lack of nutrition and frequent use of drugs to treat diseases. 
Hemolytic anemia is a form of inherited or acquired anemia 
resulting from either intravascular or extravascular RBC 
destruction. It has numerous external and internal causes 
which are either relatively harmless or are life-threatening 
in nature3. The exposure too many chemicals have also been 
associated with RBC destruction and hemolytic anemia4. The 
hemolytic activity of aryl hydrazines, such as phenyl 
hydrazine, dapsone, hydroxylamine, divicine, may lead to 
acute hemolytic anemia in vertebrates5. Yeshoda induced 
anemia in rats following a single intraperitoneal 
administration of phenylhydrazine hydrochloride (PHZ) at a 
dose of 20 mg/kg b.w. (aqueous solution). Erythrocyte 
concentration lowered to about 50% and Hb level to about 
60% of normal values in the course of 4 days6. Plant and 
plant products are being utilized as a source of medicine 
since long. Plant extracts are used as phytotherapeutics and 
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are still a large source of natural antioxidants. Natural 
antioxidants strengthen the endogenous antioxidant defense 
from ROS ravage and restored the optimal balance by 
neutralizing the reactive species7. Particularly, flavonoids 
and phenolics are considered as potential therapeutic 
agents. A wide range of ailments and is widely distributed in 
the plant kingdom and, therefore, an integral part of the diet 
with the significant amount reported in vegetables, fruits 
and beverages8. From ancient time, medicinal plants 
classified as Rasayana in Ayurveda are believed to be useful 
in strengthening the hematopoietic and immune system of 
an individual. Ayurvedic physicians suggested various herbs 
for the treatment of hematological disorders as a source of 
iron and other minerals.  Silja et al. (2008) included 
Ageratum conyzoides, Boerhavia diffusa, Centella asiatica, 
Hemidesmus indicus, Ichnocarpus frutescens, Momordica 
charantia, Moringa oleifera, Phyllunthus amarus, Phyllunthus 
emblica, Punica granatum, Ocimum tenuiflorum, Solanum 
americanum as useful plants in the treatment of anemia9. 
Adenia gummifera, Allophylus rubifolius, Albizia versicolor, 
Brackenridgea zanguebarica, Bridelia cathartica, Comniphora 
africana, Hibiscus sabdariffa, Lannea stuhlmanni, Sorgum 
bicolor, Theobroma cacao, Triumfetta rhomboidea was also 
reported to be used in conditions of anemia10-12.  
Various researchers successfully evaluated the potential of 
several medicinal plants in the treatment of anemia using 
various experimental animal models. The hematinic activity 
of an orally administered aqueous extract of Hibiscus 
cannabinus leaves was evaluated in phenylhydrazine (10 
mg/kg, p.o, for 8 days) induced anemic rats13. Tectona 
grandis leaves were evaluated on anemia model of rat 
induced by intraperitoneal injection of phenyl hydrazine at 
40 mg/kg for 2 days14. 
Fenugreek is an annual plant of the family Fabaceae. 
Fenugreek seeds have been used for a long time as a spice 
and to treat several diseases. Charred fenugreek seeds have 
been recovered from Iraq (radiocarbon dating to 4000 BC) 
and desiccated seeds have also found in the tomb of 
Tutankhamen15. There is mention of fenugreek seed as a 
natural healer in different folk and tribal literatures. In 
Ayurveda, fenugreek seed extract has been mentioned as an 
effective blood tonic, which helps in curing anemia during 
menstruation in women. Ibrahium and Hegazi (2009) 
showed that the biscuits made from fenugreek seed flour 
increased iron bioavailability, blood hemoglobin, hematocrit 
and serum iron content in experimental animal model16. 
Mahmud et al. (2012) showed that fenugreek leaf extract 
and seed extract caused significant increase in hematological 
and biochemical parameters including blood hemoglobin, 
hematocrit, total count of RBC, serum total iron binding 
capacity, serum protein and minerals (iron and zinc) in 
animal model when compared to anemia control group17. A 
clinical study in females of child bearing age indicated that 
fenugreek seed extract has good beneficial effect to raise 
blood hemoglobin18. Fenugreek seed extract has already 
shown to have antioxidant activities. Naidu et al. (2011) 
showed that the extracts of fenugreek husk, seed and 
endosperm exhibited 72%, 64% and 56% antioxidant 
activity respectively by free radical scavenging method19. 
They also mentioned the presence of saponin, protein, 
polyphenols etc. in fenugreek seed to exhibit antioxidant 
activity. Previous works ensured the role of antioxidant in 
the pathogenesis of iron deficiency anemia20. WHO declared 
iron deficiency anemia as one of the most important 
contributing factors to the global burden of diseases21. 
Present remedies available to treat iron deficiency may 
cause severe adverse effects including nausea, diarrhea, 
vomiting, anaphylaxis etc. The objective of this study aims at 
investigating the therapeutic benefit of the plant in the 
treatment of anemia. 
MATERIAL AND METHODS 
Plant material 
The seeds of plant T. foenum-graecum were purchased from 
local market of Bhopal (M.P.).The sample was identified by 
Botanist, Department of Botany, Safia College of Arts and 
Science, peer gate Bhopal. A herbarium of plants was 
submitted to the specimen library of Safia College of Arts 
and Science, peer gate Bhopal and The specimen voucher no. 
of T. foenum-graecum L is 154/Bot/Saf/Science/College. 
Chemical reagents 
All the chemicals used in this study were obtained from Hi 
Media Laboratories Pvt. Ltd. (Mumbai, India), Sigma-Aldrich 
Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem. Ltd. 
(Mumbai, India) and SRL Pvt. Ltd. (Mumbai, India).All the 
chemicals used in this study were of analytical grade.  
Extraction 
Seeds of T. foenum-graecum were purchased, washed and 
rinsed properly. They were dried in shade. Initially 250 gm 
of crude powder will be taken and packed in a packing 
paper. This pack will be placed in a soxhlet extractor & 
extracted with hydroalcoholic solvent (70:30); the 
extraction will be carried out until the drug was completely 
extracted. The extract will be then filtered with whatman 
filter papers (No.1) and the filtrate will be evaporated to 
dryness in rotary evaporator at 40ºC. The obtained crude 
extract will be stored in an air tight container free from any 
contamination until it was used. Finally the percentage 
yields were calculated of the dried extracts22. 
Animals 
Albino rats of either sex (250±25g body weight) were used 
for this study. They were housed in groups of three in 
polypropylene cage at ambient temperature (25±2°C), 
relative humidity (55±5%) and 12 hrs/12 hrs light-dark 
cycles. Animals had free access to commercial brand rat 
pellet diet and water given ad libitum. The protocol of the 
experiment was approved by the Institutional Animal Ethical 
Committee (IAEC) of Pinnacle Biomedical Research Institute 
(PBRI) Bhopal (Reg No. 1824/PO/ERe/S/15/CPCSEA) as per 
the guidance of the Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA), 
Ministry of Social Justice and Empowerment, Government of 
India. Protocol Approval Reference No. PBRI/IAEC/PN- 
18017. The studies were conducted according to the 
guidelines of CPCSEA. The standard gastric cannulas will be 
used for oral drug administration in experimental animals. 
Acute oral toxicity 
Acute toxicity study of the prepared seeds extracts was 
carried out according to the Organization for Economic Co-
Operation and Development (OECD) Guidelines-423. The 
animals were fasted for 4 h, but allowed free access to water 
throughout. As per the OECD recommendations, the starting 
dose level should be that which is most likely to produce 
mortality in some of the dosed animals; and when there is no 
information available on a substance to be tested in this 
regard; for animal welfare reasons, three animals of single 
sex are used for each step. The dose level to be used as the 
starting dose is selected from one of three fixed levels 5, 300 
and 2000 mg/kg body weight. Acute toxicity was 
determined as per reported method23. 
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Animal’s treatment  
Anemia induction  
Anemia was induced by intraperitoneal phenylhydrazine 
injection (40 mg/kg/body weight) during two days (Day 0 
and Day 1) 24,25. 
Experimental design  
The animals were distributed according to weight in five 
groups each of six rats and received by gavage during 
13days T. foenum-graecum extracts and Dexorange 
(reference drug) as follows: 
Group I (Normal): Normal control received saline.   
Group II (PHZ control): Anaemic control received 
phenylhydrazine (40 mg/kg) at day 0 and day 1 then 
distilled water daily during 13 days.   
Group III (TFG 200): In this group rats were treated with 
phenylhydrazine (40 mg/kg) at day 0 (D0) and day 1 (D1) 
then treated with T. foenum-graecum extract (200 mg/kg) 
daily during 13 days.   
Group IV (TFG 400): In this group rats were treated with 
phenylhydrazine (40 mg/kg) at day 0 (D0) and day 1 (D1) 
then treated with T. foenum-graecum extract (400 mg/kg) 
daily during 13 days.   
Group V (Dexorange): Standard control received 
phenylhydrazine (40 mg/kg) at days 0 (D0) and 1 (D1) and 
dexorange single dose 200 mg/kg per day for 13 day.  
The extracts and dexorange treatment began one day after 
phenylhydrazine administration. On completion of the 
experimental period, animals were anesthetized with 
thiopentone sodium (50 mg/kg, ip). The blood was collected 
with and without EDTA as an anticoagulant. Plasma was 
separated by centrifugation. Plasma was used for the 
estimation of various biochemical parameters. Hemoglobin 
was estimated by cyanomethaemoglobin method26. WBC and 
RBC were counted by Ochei method, 200027. 
Statistical analysis  
The values expressed as Mean ± standard deviation (SD) 
from 6 animals. In each group, the various means were 
compared with those of day 0 (D0) then day 2 (D2) by using 
one way analysis of variance (ANOVA) followed by Dunnett’s 
test. The statistical difference was considered significant at P 
< 0.05. 
 
RESULTS AND DISCUSSION  
Results  
The crude extracts so obtained after the soxhlation 
extraction process were concentrated on water bath by 
evaporation the solvents completely to obtain the actual 
yield of extraction. The yield of extracts obtained from the 
seeds of the plants using hydroalcohol as solvents was found 
to be 9.43 %. The results of qualitative phytochemical 
analysis of the crude powder seeds of T. foenum-graecum are 
shown in Table 1. Hydroalcoholic extracts of seeds sample of 
T. foenum-graecum showed the presence of flavonoids, 
phenols, tannins, carbohydrate, glycosides and proteins. The 
present study was carried out to evaluate anti anemic 
properties of hydroalcoholic extracts of T. foenum-graecum 
seeds. Hematological parameters such as red blood cells 
number (RBC), hemoglobin concentration (Hb) and white 
blood cells number (WBC) were given before treatment 
(D0), after phenylhydrazine induced anemia (D2), at first, 
second and 13 days of treatment. The mean values for whole 
animals groups before phenylhydrazine injection were 
7.84±0.252x 106/μL, 14.51±0.902 g/dL and 8.073±0.338 
103/μL respectively for RBC, Hb, and WBC. The 
intraperitoneal phenylhydrazine injection during two 
successive days involved a significant decrease (P < 0.001) 
red blood cells (3.83±0.329 x106/μL), hemoglobin 
concentration (8.11±0.540 g/dL) and white blood cells 
(4.16±0.823 x103/μL) in anemia groups compared to day 0 
(D0).  During treatment, results showed a strong increase in 
RBC at 13 days in groups treated with Dexorange 
(8.28±0.459), hydroalcoholic extracts 200 mg/kg 
(7.15±0.944) and 400 mg/kg (8.31±0.554) compared to day 
2. But red blood cells increase in untreated rats was 
progressive and reached 8.21±0.410 (Table 2 & Figure 1). 
Hemoglobin concentration was strongly restored (P < 0.001) 
in groups treated with Dexorange, hydroalcoholic extracts 
200 mg/kg and 400 mg/kg of body weight respectively to 
reach 14.54±0.411, 12.44±0.551 and 14.04±0.355 compared 
to  phenylhydrazine toxic effect at day 2. The percentage 
variation obtained at 13 days in untreated group was 
statistically identical (P > 0.05) to those obtained at second 
day in treated groups with dexorange and T. foenum-
graecum extracts (Table 3& Figure 2). White blood cells: The 
administration of phenylhydrazine also decreased WBCs at 
day D2. This decrease was (4.165± 0.823) at 2nd day and 
(5.876±0.674) at 13th day in untreated rats G2, the rats of 
groups G3, G4, and G5 the increased of WBCs at day 13 was 
(8.2±0.548), (8.43±0.447), (8.63±0.572) respectively (Table 
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Table 1 Phytochemical evaluation of T. foenum-graecum seeds extracts 
S. No. Experiment Hydroalcoholic extract 
  Present Absent 
1 Alkaloids 
1.1 Mayer’s reagent test  - 
1.2 Wagner’s reagent test  - 
1.3 Hager’s reagent test  - 
2. Carbohydrates 
2.1 Molish’s test  - 
2.2 Fehling’s test  - 
2.3 Benedict’s test  - 
2.4 Barfoed’s test  - 
3 Proteins and Amino Acids 
3.1 Biuret test  - 
4. Flavonoids 
4.1 Alkaline reagent test  - 
4.2 Lead Acetate test  - 
5. Glycoside 
5.1 Borntrager test -  
5.2 Legal’s test -  
5.3 Killer-Killiani test -  
6. Tannin and Phenolic Compounds 
6.1 Ferric Chloride test  - 
6.2 Lead Acetate test  - 
6.3 Gelatin test  - 
7. Saponin 
7.1 Foam test  - 
8. Test for Triterpenoids and Steroids 
8.1 Salkowski’s test  - 
8.2 Libbermann-Burchard’s test  - 
 
Table 2 Effect of administration of T. foenum-graecum extract on RBCs of iron deficient rats 






1 Normal control 8.17±0.302 7.16±0.046 8.21±0.410 
2 Positive control (PHZ 40 mg/kg) 8.11±0.501 3.83±0.329 4.37±0.226 
3 TFG treated group 200mg/kg 8.05±0.581 4.12±0.489 7.15±0.944 
4 TFG treated group 400mg/kg 8.11±0.291 4.00±0.431 8.31±0.554 
5 Standard (200 mg/kg) 8.12±0.325 3.72±0.537 8.28±0.459 
 
Table 3 Effect of administration of T. foenum-graecum extract on hemoglobin of iron deficient rats 






1 Normal control 14.75±0.377 14.3±0.201 14.5±0.071 
2 Positive control (PHZ 40 mg/kg) 14.32±0.528 8.11±0.540 12.2±1.639 
3 TFG treated group 200mg/kg 14.70±0.381 8.12±0.155 12.44±0.551 
4 TFG treated group 400mg/kg 14.31±0.308 8.25±0.247 14.04±0.355 
5 Standard (200 mg/kg) 14.55±0.322 8.19±0.684 14.54±0.411 
 
Table 4 Effect of administration of T. foenum-graecum extract on WBCs of iron deficient rats 






1 Normal control 8.13±0.186 7.55±0.533 8.54±0.297 
2 Positive control (PHZ 40 mg/kg) 7.37±0.705 4.165±0.823 5.876±0.674 
3 TFG treated group 200mg/kg 8.08±0.622 5.3±0.648 8.2±0.548 
4 TFG treated group 400mg/kg 8.05±0.368 5.00±0.700 8.43±0.447 
5 Standard (200 mg/kg) 8.01±0.289 3.72±0.537 8.63±0.572 
 
Chourasiya et al                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):332-337 
ISSN: 2250-1177                                                                                  [336]                                                                                 CODEN (USA): JDDTAO 
 
Figure 1 Effect of T. foenum-graecum extract on RBCs 
 
Figure 2 Effect of T. foenum-graecum extract on 
Hemoglobin 
 
Figure 3 Effect of T. foenum-graecum extract on WBCs 
DISCUSSIONS 
Anaemia is one of the public health problems most 
widespread, especially in developing countries. It is 
characterized by the deficiency of red blood cells (RBC) or 
hemoglobin in the blood, which results in the disturbance of 
the oxygen transport. The normal rate of hemoglobin varies 
with age and gender. There is anaemia when the rate is less 
than 110 g / L for pregnant women and children of 6 months 
to 5 years, 120g / L for unpregnant women and 130 g/L for 
men28. There are two groups of anaemia, the lack of 
production of red blood cells (iron deficiency, aplastic or 
megaloblastic anaemia) or the abnormal destruction of red 
blood cells (hemolytic anaemia, or anaemia caused by a 
chronic disease). Iron deficiency anaemia is the most 
common type of anaemia. It is most widespread to children 
and women of all ages. The World Health Organization 
estimates that for the entire world, anaemia reached a 
staggering 2 billion people affected, also about 50% of cases 
is due to iron deficiency28. In the case of hemolytic anemia, 
the rate of production of red blood cells is normal or high, 
but they are destroyed too rapidly. This disease is acquired 
or inherited. Acquired, it may be due to a reaction of the 
immune system (autoimmune or allergic), in the presence of 
toxic substances in the blood (phenylhydrazine) or to the 
infections. Phenylhydrazine is a non-immunogenic drug that 
induces changes in the RBC membrane which leads to 
oxidative denaturation of haemoglobin. Formation of altered 
haemoglobin takes place known as “Heinz bodies” which 
decreases the life span of the erythrocytes29. This is 
characterized by increase in incidence of micronucleated 
polychromated and hypochromic erythrocytes resulting in 
increased mean cell volume and decreased mean cell Hb 
concentration levels30.The prevalence of iron deficient 
anemia can be reduced by dietary supplementation with 
pharmaceutical preparations, iron fortification, and dietary 
diversification. Iron supplements are useful for production of 
a rapid improvement in the iron status in anemic individuals. 
Electrolytic iron and ferrous sulfate are widely used, but 
effectiveness depends on dietary bioavailability. The 
bioavailability of non-heme iron is between 2% and 20% and 
is influenced by a variety of inhibiting components in the 
diet31. Due to poor bioavailability, and other reasons, 
inorganic iron supplementation has limitations. Heme iron is 
absorbed via a heme transporter that is predominantly 
expressed in brush border membranes of duodenal 
enterocytes and hepatocytes32. In contrast, nonheme iron is 
transported into the body via nonselective iron channels33 
that are easily influenced by other metal ions. Therefore, 
absorption of heme iron in humans is more complete than 
absorption of non-heme iron. Due to good bioavailability, 
heme iron is recommended as an iron supplement. 
Phytochemical analysis revealed the presence of large 
chemical groups that are: alkaloids, flavonoids, polyphenols, 
sterols, terpenes, glycosides and saponins. They have 
antioxidant power, promote regeneration of tissue, reduce 
the permeability of blood capillaries and increase their 
resistance to hemolysis. The presence of these chemicals by 
their properties justifies the resistance of red blood cells of 
treated rats with the extract. The anti-anemic activity of T. 
foenum-graecum extract was assessed by determining the 
red blood cell count, hemoglobin and WBCs level. 
Phenylhydrazine decreased the RBC, Hb and WBCs as 
compared normal control.  
CONCLUSION 
The collective data of this study revealed that seeds have 
considerable anti-anemic activity as shown in PHZ-induced 
anemia in experimental rat model indicating the use of this 
plant for the treatment of anemia. Further studies are 
required to precisely define the bioactive and to develop 
suitable formulations to ensure maximum bioavailability and 
therapeutic efficacy. 
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